101 – 110 of 289
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
(
- Contribution to journal › Article
-
Mark
ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells.
(
- Contribution to journal › Article
-
Mark
Genetic tests need the Human Variome Project.
(
- Contribution to journal › Letter
-
Mark
Mutation (variation) databases and registries: a rationale for coordination of efforts.
(
- Contribution to journal › Letter
-
Mark
NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene.
(
- Contribution to journal › Article
-
Mark
Clarity and claims in variation/mutation databasing.
(
- Contribution to journal › Letter
- 2010
-
Mark
How to catch all those mutations--the report of the third Human Variome Project Meeting, UNESCO Paris, May 2010.
(
- Contribution to journal › Article
-
Mark
Performance of protein stability predictors.
(
- Contribution to journal › Article
-
Mark
The Human Variome Project (HVP) 2009 Forum "Towards Establishing Standards".
(
- Contribution to journal › Article
-
Mark
Different molecular behavior of CD40 mutants causing hyper-IgM syndrome.
(
- Contribution to journal › Article